NEW YORK (GenomeWeb News) – NanoString Technologies reported after the close of the market Wednesday a 55 percent increase in fourth quarter revenues, driven by strong growth for its instruments.

The Seattle-based genetic analysis systems maker reported total revenues of $10.1 million for the three months ended Dec. 31, up from $6.5 million year over year. NanoString beat analysts' consensus estimate for revenues of $9.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.